Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
JACC. Heart Failure|March 14, 2014
Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathyYuichi J Shimada, Jonathan J Passeri, Aaron L Baggish, et al.Nature Biotechnology|June 21, 2011
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular diseaseTerri A Addona, Xu Shi, Hasmik Keshishian, et al.JACC. Cardiovascular Imaging|January 21, 2023
Apical Aneurysms and Mid-Left Ventricular Obstruction in Hypertrophic CardiomyopathyMark V Sherrid, Samuel Bernard, Nidhi Tripathi, et al.Circulation|July 23, 2016
Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular DiseaseDebby Ngo, Sumita Sinha, Dongxiao Shen, et al.JACC. Advances|September 16, 2024
Clinical Course and Treatment of Patients With Apical Aneurysms Due to Hypertrophic CardiomyopathyMark V Sherrid, Daniele Massera, Samuel Bernard, et al.JACC. Advances|June 17, 2026
Clinical Spectrum and Outcomes in Hypertrophic Cardiomyopathy With Apical Aneurysms: A Large Multicenter International CohortEthan J Rowin, Deacon Z J Lee, Mark V Sherrid, et al.The Journal of Clinical Investigation|September 5, 2008
Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injuryGregory D Lewis, Ru Wei, Emerson Liu, et al.JACC. Heart Failure|February 5, 2025
Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline CharacteristicsPablo Garcia-Pavia, Ozlem Bilen, Melissa Burroughs, et al.JACC. Heart Failure|June 20, 2025
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCMSara Saberi, Theodore P Abraham, Lubna Choudhury, et al.Journal of the American College of Cardiology|January 4, 2023
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic CardiomyopathyMartin S Maron, Ahmad Masri, Lubna Choudhury, et al.Pageof 7